Top Markets
Coin of the day
Molecure S.A. Molecure S.A.

Molecure S.A.

MOC
Rang in aandelen #26168
Operating as a biopharmaceutical firm in Poland, Molecure S.A. specializes in... Operating as a biopharmaceutical firm in Poland, Molecure S.A. specializes in the research, development, and commercialization of innovative therapies designed to combat neoplastic (cancer) and inflammatory conditions. The company's pipeline prominently features OATD-01, a chitotriosidase/acidic mammalian chitinase inhibitor that has successfully advanced through Phase I clinical trials for the treatment of idiopathic pulmonary fibrosis and sarcoidosis. Additionally, Molecure is progressing its YKL-40 program for cancer and fibrosis, OATD-02 for oncology applications, and a Deubiquitinase program. Established in 2012, this Warsaw-headquartered enterprise adopted the name Molecure S.A. in March 2022, having previously been known as OncoArendi Therapeutics S.A.
Aandeelprijs
$1.73
Marktkapitalisatie
$42.88M
Verandering (1 dag)
2.16%
Verandering (1 jaar)
-18.85%
Land
PL
Handel Molecure S.A. (MOC)

Categorie

Koersgeschiedenis voor Molecure S.A. (MOC)
Hoogste slotkoers: $1.72 op 2026-08-01

Laagste slotkoers: $8.01 op 2018-04-01
Koersgeschiedenis van Molecure S.A. van 2018 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) -4.92%
2025 -23.76%
2024 -51.57%
2023 52.92%
2022 -63.44%
2021 -31.76%
2020 420.16%
2019 -41.51%
2018 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$539.98 36.93%
US
$1.03K 56.35%
NL
$120.74 -14.98%
AU
$761.87 7.04%
CH
$133.68 397.12%
US